In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 30th, 2005 | 17 | Yes |
Popular Name: 2'-Deoxy-5-fluorouridine 2'-Deoxy-5-fluorouridine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 1397179-21-3 , 2968-28-7 , 50-91-9
5-fluoro-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
5-fluoro-1-[4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4(1H,3H)-dione
5-Fluoro-2'-Deoxyuridine [50-91-9]
50-91-9; CPD001496941; Floxuridine; SAM002589947
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -1.72 | -4.89 | -10.74 | 3 | 7 | 0 | 105 | 246.194 | 2 | ↓ |
Hi High (pH 8-9.5) | -1.26 | -7.64 | -47.75 | 2 | 7 | -1 | 108 | 245.186 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
BP | 150° | Fluorochem |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 98% | Fluorochem |
PUBCHEM_PATENT_ID | EP0009882A1; EP0033341A1; EP0045944A1; EP0048022A2; EP0081386A1; EP0129984A1; EP0151189A1; EP0180188A2; EP0180188B1; EP0183843A1; EP0195805A1; EP0202056A1; EP0214299A1; EP0214299B1; EP0226753A2; EP0226753B1; EP0227844A1; EP0227844B1; EP0247381A2; EP024738 | IBM Patent Data |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : F-5003; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE CRYSTALLINE POWDER | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: F-5003; SUPPLIER_COMMENTS: WHITE CRYSTALLINE POWDER | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TYSY-1-E | Thymidylate Synthase (cluster #1 Of 3), Eukaryotic | Eukaryotes | 7300 | 0.42 | Binding ≤ 10μM |
Z80064-6-O | CCRF-CEM (T-cell Leukemia) (cluster #6 Of 9), Other | Other | 500 | 0.52 | Functional ≤ 10μM |
Z80101-2-O | COLO 320DM (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other | Other | 650 | 0.51 | Functional ≤ 10μM |
Z80120-3-O | DLD-1 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other | Other | 92 | 0.58 | Functional ≤ 10μM |
Z80164-4-O | HT-1080 (Fibrosarcoma Cells) (cluster #4 Of 6), Other | Other | 120 | 0.57 | Functional ≤ 10μM |
Z80193-2-O | L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other | Other | 45 | 0.61 | Functional ≤ 10μM |
Z80208-1-O | L5178Y (Lymphoma Cells) (cluster #1 Of 2), Other | Other | 2 | 0.72 | Functional ≤ 10μM |
Z80268-2-O | MKN-28 (Gastric Epithelial Carcinoma Cells) (cluster #2 Of 2), Other | Other | 120 | 0.57 | Functional ≤ 10μM |
Z80269-3-O | MKN-45 (Gastric Adenocarcinoma Cells) (cluster #3 Of 3), Other | Other | 3500 | 0.45 | Functional ≤ 10μM |
Z80347-2-O | NUGC-3 (Gastric Carcinoma Cells) (cluster #2 Of 2), Other | Other | 15 | 0.64 | Functional ≤ 10μM |
Z80525-2-O | SW48 (cluster #2 Of 2), Other | Other | 130 | 0.57 | Functional ≤ 10μM |
Z80532-1-O | T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other | Other | 120 | 0.57 | Functional ≤ 10μM |
Z80682-9-O | A549 (Lung Carcinoma Cells) (cluster #9 Of 11), Other | Other | 1000 | 0.49 | Functional ≤ 10μM |
Z80686-1-O | AZ-521 Cell Line (cluster #1 Of 1), Other | Other | 50 | 0.60 | Functional ≤ 10μM |
Z81048-1-O | TSU (Prostatic Carcinoma Cells) (cluster #1 Of 2), Other | Other | 58 | 0.60 | Functional ≤ 10μM |
Z81121-1-O | KKLS Cell Line (cluster #1 Of 1), Other | Other | 760 | 0.50 | Functional ≤ 10μM |
Z81137-1-O | L929 (Fibroblast Cells) (cluster #1 Of 2), Other | Other | 7700 | 0.42 | Functional ≤ 10μM |
Z81170-4-O | LNCaP (Prostate Carcinoma) (cluster #4 Of 5), Other | Other | 69 | 0.59 | Functional ≤ 10μM |
Z81330-1-O | SNU- (cluster #1 Of 1), Other | Other | 3 | 0.70 | Functional ≤ 10μM |
Z81335-3-O | HCT-15 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other | Other | 49 | 0.60 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TYSY_MOUSE | P07607 | Thymidylate Synthase, Mouse | 20 | 0.63 | Binding ≤ 1μM |
TYSY_MOUSE | P07607 | Thymidylate Synthase, Mouse | 20 | 0.63 | Binding ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 1000 | 0.49 | Functional ≤ 10μM |
Z80686 | Z80686 | AZ-521 Cell Line | 50 | 0.60 | Functional ≤ 10μM |
Z80064 | Z80064 | CCRF-CEM (T-cell Leukemia) | 2 | 0.72 | Functional ≤ 10μM |
Z80101 | Z80101 | COLO 320DM (Colon Adenocarcinoma Cells) | 650 | 0.51 | Functional ≤ 10μM |
Z80120 | Z80120 | DLD-1 (Colon Adenocarcinoma Cells) | 92 | 0.58 | Functional ≤ 10μM |
Z81335 | Z81335 | HCT-15 (Colon Adenocarcinoma Cells) | 49 | 0.60 | Functional ≤ 10μM |
Z80164 | Z80164 | HT-1080 (Fibrosarcoma Cells) | 120 | 0.57 | Functional ≤ 10μM |
Z81121 | Z81121 | KKLS Cell Line | 760 | 0.50 | Functional ≤ 10μM |
Z80193 | Z80193 | L1210 (Lymphocytic Leukemia Cells) | 0.5 | 0.77 | Functional ≤ 10μM |
Z80208 | Z80208 | L5178Y (Lymphoma Cells) | 0.76 | 0.75 | Functional ≤ 10μM |
Z81137 | Z81137 | L929 (Fibroblast Cells) | 7700 | 0.42 | Functional ≤ 10μM |
Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 69.2 | 0.59 | Functional ≤ 10μM |
Z80268 | Z80268 | MKN-28 (Gastric Epithelial Carcinoma Cells) | 120 | 0.57 | Functional ≤ 10μM |
Z80269 | Z80269 | MKN-45 (Gastric Adenocarcinoma Cells) | 3500 | 0.45 | Functional ≤ 10μM |
Z80347 | Z80347 | NUGC-3 (Gastric Carcinoma Cells) | 15 | 0.64 | Functional ≤ 10μM |
Z81330 | Z81330 | SNU- | 3.3 | 0.70 | Functional ≤ 10μM |
Z80525 | Z80525 | SW48 | 130 | 0.57 | Functional ≤ 10μM |
Z80532 | Z80532 | T-24 (Bladder Carcinoma Cells) | 120 | 0.57 | Functional ≤ 10μM |
Z81048 | Z81048 | TSU (Prostatic Carcinoma Cells) | 58 | 0.60 | Functional ≤ 10μM |
Description | Species |
---|---|
E2F mediated regulation of DNA replication | |
G1/S-Specific Transcription | |
Pyrimidine biosynthesis |